Truveta’s Post

A recent study in JMIR Publications Public Health and Surveillance Journal by researchers from the Institute for Systems Biology leveraged Truveta Data to better understand treatments for pregnant patients who were hospitalized with #COVID19. Read the summary: https://tr.vet/3OeuA77 #PeerReviewed #MaternalHealth #COVID #HealthData #HealthTech #HealthInsights #HealthInnovation

Scientists from the Institute for Systems Biology recently published a study leveraging Truveta Data in JMIR Publications Public Health and Surveillance Journal about treatments for pregnant patients who were hospitalized with #COVID19. Read the summary: https://tr.vet/3OeuA77 #PeerReviewed #MaternalHealth #COVID #HealthData #HealthTech #HealthInsights #HealthInnovation

"Comparable datasets often rely on claims data, which may lack detail on clinical outcomes and patient journeys. Truveta data addresses these challenges by providing a comprehensive, longitudinal view of patient care, empowering researchers to make significant strides in maternal and pediatric health care." Read about our mother-child EHR dataset, the largest of its kind with more than 1M pairs, via The Evidence Base®: https://tr.vet/3JCoM5H #MotherChildData #PediatricData #MaternalHealthCare #MaternalHealthData #HealthData #HealthEquity #HealthAI #HealthInnovation #MaternalResearch #PediatricResearch

Researchers from the Institute for Systems Biology recently published a study citing Truveta Data in JMIR Publications Public Health and Surveillance Journal about treatments for pregnant patients who were hospitalized with #COVID19. Read the summary of their findings: https://tr.vet/3OeuA77 #PeerReviewed #MaternalHealth #COVID #HealthData #HealthTech #HealthInsights #HealthInnovation

How Babio Changed Lives: Real User Stories 🌟🧪 Discover the transformative impact of Babio’s diagnostic kits through real-life applications and news stories. 🏠 Early Detection of Pregnancy In numerous reports, early detection of pregnancy using reliable home test kits has empowered individuals to seek timely prenatal care. For example, a study published in the Journal of the American Medical Association emphasized how early pregnancy tests can improve outcomes by allowing earlier medical intervention. Impact: Timely Care: Early detection leads to early prenatal care, improving health outcomes for both mother and child. Peace of Mind: Reliable results help individuals make informed decisions about their health. 🏥 Streamlined Clinical Workflow Healthcare facilities, particularly during the COVID-19 pandemic, have relied heavily on rapid diagnostic tests to manage patient care efficiently. According to a report by the Centers for Disease Control and Prevention (CDC), rapid testing kits have been pivotal in quickly identifying cases, thereby streamlining treatment and isolation protocols. Impact: Efficiency: Quick results reduce waiting times, allowing for faster clinical decisions. Reliability: High accuracy rates improve diagnostic confidence among healthcare providers. 🌍 Travel and COVID-19 Testing During the COVID-19 pandemic, rapid antigen tests were critical for safe travel. An article in The New York Times detailed how travelers used these tests to meet travel requirements and ensure safety. These tests allowed travelers to confirm their health status before boarding flights, helping to prevent the spread of the virus. Impact: Convenience: Easy-to-use kits provided quick results, meeting travel requirements. Safety: Regular testing facilitated safe travel, preventing the spread of COVID-19. 🏫 School Health Programs Schools have implemented rapid diagnostic tests to maintain a safe environment for students and staff. For instance, CNN reported on how schools utilized these tests to quickly identify and isolate cases of infectious diseases, thereby preventing outbreaks and ensuring continuous in-person education. #babioinaction #HealthSuccessStories #patientcare #Diagnostickits #lifechanging #healthcareinnovation #RealTestimonials #HealthMonitoring #TrustedResults

●TRANSFORMATIVE MATERNAL AND NEWBORN HEALTHCARE IN TANZANIA.

A treatment to move blood from the umbilical cord into an infant’s body may provide a safe option for preterm infants born after 28 weeks who need rapid support, suggests a study supported by the National Institutes of Health. Umbilical cord milking involves gently squeezing the cord between the thumb and forefinger and pushing the blood into the newborn’s abdomen. The new findings suggest that concerns raised by a previous study of infants born before 28 weeks—which concluded that umbilical cord milking might increase the risk of bleeding inside the brain—do not apply to preterm infants born after 28 weeks. Learn more at https://go.nih.gov/zPy0TQF. Sharp HealthCare Anup Katheria #NICHDimpact

Did you know that the U.S. maternal mortality rate stands at a shocking ten times higher than that of other wealthy nations? Even more concerning is that a staggering 84% of these tragic deaths are preventable. Black and Hispanic women, particularly those grappling with immune-mediated conditions like lupus, face an even greater risk during pregnancy and childbirth.  Johnson & Johnson Innovative Medicine Research & Development team, in partnership with the Office of the Chief Medical Officer Health of Women, initiated the Maternal-Fetal Immune Disorders QuickFire Challenge in 2022 to tackle these disparities head-on. The two awardees of the QFC, Acclinate and NX PRENATAL INC., are leading the charge in revolutionizing maternal-fetal healthcare. Through their innovative, data-driven methodologies, they're shedding light on the root causes of health disparities and paving the way for transformative solutions that will help save lives.  Read the latest article co-written by Johnson & Johnson’s very own Kattayoun (Kathy) Kordy, M.D., Head of Rare Disease, and Ashley Orillion, PhD, Principal Scientist: https://bit.ly/3VbScyu #JNJImmunology

Pediatric rare diseases are hard enough on patients and their loved ones. Make it easier on them by incorporating DCT strategies. See how this helps sponsors increase access, enrollment, and retention: https://lnkd.in/eY52-GTp Thanks to our experts: Betsy Reid and Adam Bloomfield MD FAAP #WebinarRecording #PediatricTrials #PediatricRareDisease #ClinicalTrials #RareDiseases #DecentralizedClinicalTrials

I'm delighted to share our systematic review and meta-analysis published on Sage Medicine on the title #Magnitude, disparity, and predictors of poor-quality antenatal care service: A systematic review and meta-analysis With these strong recommendation and policy implication : This study revealed regional and country-level disparities where pregnant women who resided in Asia, Africa, and the South American continents had the lowest quality antenatal care services provided. Therefore, policymakers and health planners would put a great deal of emphasis on addressing the quality of antenatal care services. 1. Policymakers and global funders need to invest resources to monitor and improve the quality of antenatal care in order to meet the global maternal mortality target as per the SDGS plan by shifting health systems from coverage of ANC services to quality of ANC services based on World Health Organization (WHO) quality ANC contents. 2. Health care systems in LMICs should provide high-quality ANC based on WHO recommendations for pregnant women in need of quality services at all levels. 3. The Ministry of Health should maintain high-quality antenatal care services per nationally accepted WHO recommendations at all levels. 4. Policymakers and health planners should prioritize the quality of ANC services as part of current international and national public health agendas to reduce maternal and neonatal mortality and morbidities as per SDG Plan 2030. avaiable